Literature DB >> 5743707

Phase II study of azotomycin (NSC-56654).

A J Weiss, G Ramirez, T Grage, J Strawitz, L Goldman, V Downing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5743707

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  2 in total

1.  Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas.

Authors:  R H Earhart; D J Amato; A Y Chang; E C Borden; M Shiraki; M E Dowd; R L Comis; T E Davis; T J Smith
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

2.  Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON).

Authors:  A Rahman; F P Smith; P T Luc; P V Woolley
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.